The Food and Drug Administration has approved a new generic version of the abortion pill mifepristone, prompting an outcry from conservatives who’ve been eager to restrict access to the medication.
The generic pill was approved in September, according to Evita Solutions, its manufacturer. It joins another generic pill that’s already on the market from GenBioPro, which was approved in 2019.
Andrew Dixon, a spokesperson for the Health and Human Services Department, noted that the FDA “has very limited discretion in deciding whether to approve a generic dMore...rug. By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is idMore...entical to the brand-name drug.”
The North Dakota supreme court revived the state’s abortion ban on Friday, once again making it...
